ArticleFrontiers in oncology2022

Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study.

Cecilia Arthur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.